



Title: Sexual Dysfunction and Pelvic Floor Dysfunction in Patients with Systemic Rheumatic 
Diseases 
Objectives: To assess sexual functions, quality of life and pelvic floor function in female 
patients with Systemic Sclerosis (SSc) and Idiopathic Inflammatory Myopathies (IIM) 
compared to age-/sex-matched healthy controls (HC). 
Methods: In total, 41 women with SSc (mean age: 50.9, disease duration: 5.8 years), who 
fulfilled the ACR/EULAR 2013 classification criteria for SSc, 41 healthy controls (mean age: 
50.9) without rheumatic diseases, 22 women with IIM [mean age: 55.1, disease duration: 7.9 
years, dermatomyositis (DM, 8)/ polymyositis (PM, 10)/ necrotizing myopathy (IMNM, 3)/ 
inclusion body myositis (IBM, 1)], who fulfilled the Bohan/Peter 1975 diagnostic criteria for 
DM/PM, and 22 healthy controls (mean age: 55.1 years) filled in 12 well-established and 
validated questionnaires assessing sexual function/quality of life, pelvic floor function, fatigue, 
physical activity and depression.  
Results: Compared to HC, patients with SSc and IIM had significantly higher prevalence and 
greater severity of sexual dysfunction (FSFI, BISF-W: in all subscales as well as total scores), 
dysfunction of pelvic floor (PISQ-12), and worse sexual quality of life (SQoL-F). Worse scores 
in SSc patients were associated with higher disease activity [ESSG activity index: SQol-F (r=-
0.364, p=0.0443)], greater fatigue [all three questionnaires FSS/FIS/MAF correlated negatively 
with FSFI, BISF-W], more severe depression [BDI-II: FSFI (r=-0.553, p=0.0002), BISF-W (r=-
0.514, p=0.0007)], deteriorated quality of life [SHAQ: FSFI (r=-0.536, p=0.0003), BISF-W 
(r=-0.563, p=0.0001), PFIQ7 (r=0.380, p=0.0142)], and worse ability to perform physical 
activities [HAP: FSFI (r=0.407, p=0.0082), BISF-W (r=0.409, p=0.0078)]. Worse scores in IIM 
patients were associated with elevated muscle enzyme levels [lactate dehydrogenase: FSFI (r=-
0.524, p=0.0123), BISFW (r=-0.528, p=0.0115)], greater fatigue [FIS: FSFI (r=-0.434, 
p=0.0438), BISF-W (r=-0.488, p=0.0211)], more severe depression [BDI-II: PISQ-12 (r=0.474, 
p=0,0258)], deteriorated quality of life [HAQ: PISQ-12 (r=0.476, p=0.0252)], and worse ability 
to perform physical activities [HAP: FSFI (r=0.437, p=0.0417), BISF-W (r=0.451, p=0.0351), 
PISQ-12 (r=-0.494, p=0.0195)]. 
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